
Synthesizable by Design: Rethinking AI's Role in Small Molecule Drug Discovery
In this episode of Data in Biotech, host Ross Katz sits down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, for a conversation on what it actually takes to find a drug molecule that works not just on pap








